Joseph C. Papa - 25 Jun 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Reporting relationship: Director
Issuer ticker: CADL
Reported as of: 25 Jun 2025
Net transaction value: +$299,996
SEC form: 4
Accepted by SEC: 26 Jun 2025, 08:30:04 UTC
Prior SEC filing: 18 Jun 2025
Next SEC filing: 15 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Charles Schoch, as Attorney-In-Fact for Joseph C. Papa

Key filing fact

Joseph C. Papa filed Form 4 for Candel Therapeutics, Inc. (CADL) on 26 Jun 2025.

Key facts

This page summarizes Joseph C. Papa's Form 4 filing for Candel Therapeutics, Inc. (CADL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Jun 2025, 08:30.

Change

Previous filing in this sequence was filed on 18 Jun 2025.
Current net transaction value: +$299,996.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001242215 Primary reporting owner

PAPA JOSEPH C

Relationship: Director
Address: C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM
Signature: /s/ Charles Schoch, as Attorney-In-Fact for Joseph C. Papa
Signature date: 26 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CADL transaction

Common Stock

Award

Transaction value: $299,996
Shares: +64,239
Change %
Price: $4.67
Shares after: 64,239
Date: 25 Jun 2025
Ownership: By Joseph C. Papa Revocable Living Trust
Footnotes: F1, F2

CADL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 38,032
Date: 25 Jun 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.

Footnote F2

Shares held by Joseph C. Papa Revocable Living Trust, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.